We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $26 · 5 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
JCAP Q1 2026 Earnings: EPS Surpasses Estimates by 4.48%, Shares Edge Lower - Book Value Growth - thelegaladvocate.com
JCAP Q1 2026 Earnings: EPS Surpasses Estimates by 4.48%, Shares Edge Lower - Book Value Growth thelegaladvocate.com
JCAP Q1 2026 Earnings: EPS Surprise Lifts Expectations Amid Narrow Revenue Disclosures - Earnings Forecast Report - thelegaladvocate.com
JCAP Q1 2026 Earnings: EPS Surprise Lifts Expectations Amid Narrow Revenue Disclosures - Earnings Forecast Report thelegaladvocate.com
Assessing Jefferson Capital (JCAP) Valuation After Recent Share Price Weakness - simplywall.st
Assessing Jefferson Capital (JCAP) Valuation After Recent Share Price Weakness simplywall.st
Jefferson Capital (JCAP) Margin Compression Reinforces Bearish Narrative Despite Q1 2026 Revenue Strength - simplywall.st
Jefferson Capital (JCAP) Margin Compression Reinforces Bearish Narrative Despite Q1 2026 Revenue Strength simplywall.st
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 12. | After market close (AMC) | $0.71 | — | — | $170.25M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $0.61 | — | — | $154.94M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $6.6 | — | — | $314.36M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $78.26 | — | — | $203.76M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2025. 12. 25. | Keefe, Bruyette & Woods | — | Maintain | Outperform → Outperform | — | Keefe, Bruyette & Woods: Outperform |
| 2025. 11. 17. | Keefe, Bruyette & Woods | — | Maintain | Outperform → Outperform | — | Keefe, Bruyette & Woods: Outperform |
| 2025. 11. 15. | Citizens | — | Maintain | Market Outperform → Market Outperform | — | Citizens: Market Outperform |
| 2025. 07. 21. | Raymond James | — | Initiate coverage | — → Outperform | — | Raymond James: Outperform |
| 2025. 07. 21. | JMP Securities | — | Initiate coverage | — → Market Outperform | — | JMP Securities: Market Outperform |
| 2025. 07. 21. | Truist Securities | — | Initiate coverage | — → Buy | — | Truist Securities: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.